The Japan working group for the assessment that the alpha-glucosidase inhibitor blocks cardiac events in patients with myocardial infarction and IGT.

Trial Profile

The Japan working group for the assessment that the alpha-glucosidase inhibitor blocks cardiac events in patients with myocardial infarction and IGT.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Voglibose (Primary)
  • Indications Glucose intolerance; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms ABC
  • Most Recent Events

    • 31 Oct 2012 Status changed from active, no longer recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
    • 20 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 07 Sep 2012 Planned end date changed from 1 Apr 2009 to 31 May 2013 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top